Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure
- PMID: 25539945
- PMCID: PMC5573172
- DOI: 10.1136/heartjnl-2014-306890
Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure
Abstract
Objective: To determine the prevalence, correlates and prognostic implications of anaemia and iron deficiency (ID) in patients with heart failure (HF) in Tanzania.
Method: This was a cross-sectional and prospective observational study conducted at Muhimbili National Hospital in Dar es Salaam, Tanzania. Patients were ≥ 18 years of age, with HF defined according to the Framingham criteria. The primary outcome was anaemia and the secondary outcome was a composite of hospitalisation for HF or all-cause mortality.
Results: A total of 401 HF patients (median age 56 years, IQR 41-67 years; women 51%) were included. The prevalence of anaemia was 57%. The overall prevalence of ID was 49% distributed as 69% versus 21% in subjects with and without anaemia (p < 0.001). Normocytic anaemia was seen in 18% of the patients while none had macrocytic anaemia. The risk of having anaemia was positively associated with residency outside Dar es Salaam (OR 1.72 (95% CI 1.02 to 2.89); p = 0.038), atrial fibrillation (4.12 (1.60 to 10.61); p=0.003), LVEF < 45% (2.70 (1.57 to 4.67); p < 0.001) and negatively (ORs per unit decrease) with creatinine clearance (0.98 (0.97 to 0.99); p = 0.012) and total cholesterol (0.78 (0.63 to 0.98); p = 0.029). One-year survival free from a composite endpoint was 70%. The presence of ID anaemia increased the likelihood for an event (HR 2.67; 95% CI 1.39 to 5.07; p = 0.003), while anaemia without ID did not influence the risk.
Conclusions: ID anaemia was common in Tanzanian patients with HF and was independently associated with the risk for hospitalisation or death.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Figures
Comment in
-
Heart failure and iron deficiency anaemia: a complex dance.Heart. 2015 Apr;101(8):579-80. doi: 10.1136/heartjnl-2014-307227. Epub 2015 Jan 30. Heart. 2015. PMID: 25637371 No abstract available.
References
-
- Mahfoud F, Kindermann I, Kindermann M, et al. [Comorbidity: anemia and heart failure] Dtsch Med Wochenschr. 2009;134:825–30. - PubMed
-
- Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52:818–27. - PubMed
-
- O’Meara E, Clayton T, McEntegart MB, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006;113:986–94. - PubMed
-
- Androne AS. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226–9. - PubMed
-
- Nanas JN, Matsouka C, Karageorgopoulos D, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol. 2006;48:2485–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous